Skip to main content
Log in

α-Fetoprotein, tissue polypeptide antigen and ferritin in diagnosing primary hepatocellular carcinoma in patients with liver cirrhosis

  • Original Papers
  • Clinical Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

This study was undertaken in order to compare the usefulness of three indices of tumour proliferation in detecting primary hepatocellular carcinoma (HCC) and in differentiating this neoplasm from liver cirrhosis. In 10 patients with HCC and in 63 with liver cirrhosis serum α-fetoprotein (AFP), tissue polypeptide antigen (TPA) and ferritin were assayed. Increased levels of AFP but not of TPA and ferritin were observed in HCC as compared to liver cirrhosis. The receiver-operating characteristic curves demonstrated that AFP is more discriminating between HCC and liver cirrhosis than the other two markers. Correlations between liver function tests and serum markers were observed in liver cirrhosis but not in HCC. We can conclude that AFP is more useful than TPA and ferritin in detecting HCC in patients with liver cirrhosis, owing to the high frequency of false positive results of the latter two indices in liver cirrhosis. Liver dysfunction is probably involved in increasing all these markers of malignancy, thus reducing the specificity of these tests.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

AFP:

α-tetoprotein

TPA:

tissue polypeptide antigen

HCC:

primary hepatocellular carcinoma

References

  • Begent RHJ (1984) The value of carcinoembryonic antigen measurement in clinical practice. Ann Clin Biochem 21:231–238

    Google Scholar 

  • Chapman RW, Bassendine MF, Laulicht M, Gorman A, Thomas HC, Sherlock S, Hoffbrand AV (1982) Serum ferritin and binding of serum ferritin to conccanavalin A as a tumor marker in patients with primary liver cell cancer and chronic liver disease. Dig Dis Sci 27:111–116

    Google Scholar 

  • Chen D-S, Sung J-L, Sheu J-C, Lai M-Y, How S-W, Hsu H-C, Lee C-S, Wei T-C (1984) Serum α-fetoprotein in the early stage of human hepatocellular carcinoma. Gastroenterology 86:1404–1409

    Google Scholar 

  • Ebara M, Ohto M, Shinagawa T, Sugiura N, Kimura K, Matsutani S, Morita M, Saisho H, Tsuchiya Y, Okuda K (1986) Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology 90:289–298

    Google Scholar 

  • Giannoulis E, Arvanitakis C, Nikopoulos A, Doutsos I, Tourkantonis A (1984) Diagnostic value of serum ferritin in primary hepatocellular carcinoma. Digestion 30:236–241

    Google Scholar 

  • Guenther WC (1964) Analysis of variance. Prentice-Hall, Englewood Cliffs, pp 143–151

    Google Scholar 

  • Heptner G, Domschke S, Domschke W (1986) The role of tumor markers in the diagnosis and management of gastrointestinal cancer. Hepatogastroenterology 33:140–144

    Google Scholar 

  • Kew MC, Berger EL (1986) The value of serum concentrations of tissue polypeptide antigen in the diagnosis of hepatocellular carcinoma. Cancer 58:127–130

    Google Scholar 

  • Leandro G, Zizzari S, Piccoli A, Manghisi OG (1989) The serum tissue polypeptide antigen in detecting hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology (in press)

  • Nitti D, Fabris C, Del Favero G, Farini R, Grassi F, Farini A, Baccaglini U, Pedrazzoli S, Piccoli A, Lise M, Naccarato R (1982) Serum ferritin in pancreatic disease. An accurate test of malignancy. Digestion 25:258–262

    Google Scholar 

  • Oelberg DG, Lester R (1986) Cellular mechanisms of cholestasis. Annu Rev Med 37:297–317

    Google Scholar 

  • Pagliaro L, Rinaldi F, Craxi A, Di Franco C, Di Piazza S, Filippazzo G Magrin S, Maringhini A, Palazzo V, Vinci M (1982) Predictive value of clinical, laparoscopic and histologic indicators of cirrhosis. Ital J Gastroenterol 14:166–168

    Google Scholar 

  • Sheu J-C, Sung J-L, Chen D-S, Lai M-Y, Wang T-H, Yu J-Y, Yang P-M, Chuang C-N, Yang P-C, Lee C-S, Hsu H-C, How S-W (1985) Early detection of hepatocellular carcinoma by real-time ultrasonography. Cancer 56:660–666

    Google Scholar 

  • Simonetti RG, Craxi A, Dardanoni G, Lanzarone F, Barbaria F, Cottone M, Pagliaro L (1985) The clinical value of serum ferritin in hepatocellular carcinoma. Hepatogastroenterology 32:276–278

    Google Scholar 

  • Thomas P, Zamcheck N (1983) Role of the liver in clearance and excretion of circulating carcinoembryonic antigen (CEA). Dig Dis Sci 28:216–224

    Google Scholar 

  • Weinstein MC, Fineberg HV (1980) Clinical decision analysis. Saunders, Philadelphia, p 114

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Partially supported by a grant of the Italian National Research Council, Special Project “Oncology”, contract 87.01.541.04. Under the auspices of the “R. Farini association for gastroenterological research”

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leandro, G., Basso, D., Fabris, C. et al. α-Fetoprotein, tissue polypeptide antigen and ferritin in diagnosing primary hepatocellular carcinoma in patients with liver cirrhosis. J Cancer Res Clin Oncol 115, 276–278 (1989). https://doi.org/10.1007/BF00391702

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00391702

Key words

Navigation